| Date Filed | Type | Description |
| 03/22/2023 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 420 shares
@ $11.99, valued at
$5k
|
|
| 03/17/2023 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 670 shares
@ $10.71, valued at
$7.2k
|
|
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/13/2023 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Granted 115,000 shares
@ $0 |
|
| 12/22/2022 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 500 shares
@ $7.65, valued at
$3.8k
|
|
| 11/18/2022 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 150 shares
@ $7.1, valued at
$1.1k
Bought 150 shares
@ $7.2, valued at
$1.1k
|
|
| 09/27/2022 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 220 shares
@ $7.87, valued at
$1.7k
|
|
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |